UCB — Board/Management Information 2016

Mar 25, 2016

Ulf Wiinberg

Ulf Wiinberg is a pharmaceutical industry professional. Ulf started as a sales representative at Lederle Laboratories in Sweden, which later was acquired by Wyeth. At Wyeth, Ulf was President of the global consumer health care business, and later President for the European pharma business and strategically responsible for biotechnology and vaccines. Ulf served as a member of the management committee from 2002-2008. From 2008 to end of 2014, Ulf was the CEO of Lundbeck, a Danish company focusing on brain diseases.

During his career, Ulf has worked on development and in production of pharmaceutical products and vaccines that can make a big difference for patients. Ulf has also served on the boards of the industry associations for the pharmaceutical and consumer healthcare business, Pharma, Efpia and WSMI.

Ulf is today a non-executive Board member at Alfa Laval, a Swedish industrial company, and Nestle Health and Science, a consumer healthcare company. He is also the Chairman of Avillion, a company that helps large pharmaceutical companies finance and operate late stage development programs.